Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.
2.

17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients.

Wieten RW, Goorhuis A, Jonker EFF, de Bree GJ, de Visser AW, van Genderen PJJ, Remmerswaal EBM, Ten Berge IJM, Visser LG, Grobusch MP, van Leeuwen EMM.

J Infect. 2016 Jun;72(6):713-722. doi: 10.1016/j.jinf.2016.02.017. Epub 2016 Mar 24.

PMID:
27017899
3.

A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination.

Wieten RW, Jonker EF, van Leeuwen EM, Remmerswaal EB, Ten Berge IJ, de Visser AW, van Genderen PJ, Goorhuis A, Visser LG, Grobusch MP, de Bree GJ.

PLoS One. 2016 Mar 15;11(3):e0149871. doi: 10.1371/journal.pone.0149871. eCollection 2016.

4.

Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication.

Wieten RW, Jonker EF, Pieren DK, Hodiamont CJ, van Thiel PP, van Gorp EC, de Visser AW, Grobusch MP, Visser LG, Goorhuis A.

Vaccine. 2016 Mar 4;34(10):1247-51. doi: 10.1016/j.vaccine.2016.01.037. Epub 2016 Feb 1.

PMID:
26845742
5.

A privacy preserving protocol for tracking participants in phase I clinical trials.

El Emam K, Farah H, Samet S, Essex A, Jonker E, Kantarcioglu M, Earle CC.

J Biomed Inform. 2015 Oct;57:145-62. doi: 10.1016/j.jbi.2015.06.019. Epub 2015 Jul 2.

6.

Correction: a systematic review of re-identification attacks on health data.

El Emam K, Jonker E, Arbuckle L, Malin B.

PLoS One. 2015 Apr 16;10(4):e0126772. doi: 10.1371/journal.pone.0126772. eCollection 2015. No abstract available.

7.

Advances and controversies in yellow fever vaccination.

Jonker EF, Visser LG, Roukens AH.

Ther Adv Vaccines. 2013 Nov;1(4):144-52. doi: 10.1177/2051013613498954. Review.

8.

Secure surveillance of antimicrobial resistant organism colonization or infection in Ontario long term care homes.

El Emam K, Arbuckle L, Essex A, Samet S, Eze B, Middleton G, Buckeridge D, Jonker E, Moher E, Earle C.

PLoS One. 2014 Apr 8;9(4):e93285. doi: 10.1371/journal.pone.0093285. eCollection 2014.

9.

Evaluating the risk of patient re-identification from adverse drug event reports.

El Emam K, Dankar FK, Neisa A, Jonker E.

BMC Med Inform Decis Mak. 2013 Oct 5;13:114. doi: 10.1186/1472-6947-13-114.

10.

Can anonymous posters on medical forums be reidentified?

Bobicev V, Sokolova M, El Emam K, Jafer Y, Dewar B, Jonker E, Matwin S.

J Med Internet Res. 2013 Oct 3;15(10):e215. doi: 10.2196/jmir.2514.

11.

Yellow fever revaccination guidelines change - a decision too feverish?

Grobusch MP, Goorhuis A, Wieten RW, Verberk JD, Jonker EF, van Genderen PJ, Visser LG.

Clin Microbiol Infect. 2013 Oct;19(10):885-6. doi: 10.1111/1469-0691.12332. Epub 2013 Aug 8. No abstract available.

12.

A review of evidence on consent bias in research.

El Emam K, Jonker E, Moher E, Arbuckle L.

Am J Bioeth. 2013;13(4):42-4. doi: 10.1080/15265161.2013.767958. No abstract available.

PMID:
23514396
13.

Two h-index benchmarks for evaluating the publication performance of medical informatics researchers.

El Emam K, Arbuckle L, Jonker E, Anderson K.

J Med Internet Res. 2012 Oct 18;14(5):e144. doi: 10.2196/jmir.2177.

14.

P2P watch: personal health information detection in peer-to-peer file-sharing networks.

Sokolova M, El Emam K, Arbuckle L, Neri E, Rose S, Jonker E.

J Med Internet Res. 2012 Jul 9;14(4):e95. doi: 10.2196/jmir.1898.

15.

A systematic review of re-identification attacks on health data.

El Emam K, Jonker E, Arbuckle L, Malin B.

PLoS One. 2011;6(12):e28071. doi: 10.1371/journal.pone.0028071. Epub 2011 Dec 2. Erratum in: PLoS One. 2015;10(4):e0126772.

16.

The re-identification risk of Canadians from longitudinal demographics.

El Emam K, Buckeridge D, Tamblyn R, Neisa A, Jonker E, Verma A.

BMC Med Inform Decis Mak. 2011 Jun 22;11:46. doi: 10.1186/1472-6947-11-46.

17.

Physician privacy concerns when disclosing patient data for public health purposes during a pandemic influenza outbreak.

El Emam K, Mercer J, Moreau K, Grava-Gubins I, Buckeridge D, Jonker E.

BMC Public Health. 2011 Jun 9;11:454. doi: 10.1186/1471-2458-11-454.

18.

How strong are passwords used to protect personal health information in clinical trials?

El Emam K, Moreau K, Jonker E.

J Med Internet Res. 2011 Feb 11;13(1):e18. doi: 10.2196/jmir.1335.

19.
20.

The inadvertent disclosure of personal health information through peer-to-peer file sharing programs.

El Emam K, Neri E, Jonker E, Sokolova M, Peyton L, Neisa A, Scassa T.

J Am Med Inform Assoc. 2010 Mar-Apr;17(2):148-58. doi: 10.1136/jamia.2009.000232.

Supplemental Content

Loading ...
Support Center